Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.26 -0.30 (-3.14%)
As of: Oct 1, 2026 · 3:59 PM EDT

Xeris Biopharma Holdings (XERS) Other Non-Current Liabilities (2020 - 2026)

Updated

Xeris Biopharma Holdings' Other Non-Current Liabilities came in at $12.72 million for Q2 2026, up 64.1% from $7.75 million a year earlier and up 56.5% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Xeris Biopharma Holdings' Other Non-Current Liabilities was $8.4 million, up 326.9% from FY2024.

  • Other Non-Current Liabilities carries a five-year compound annual growth rate of 4.8% (FY2020 to FY2025).
  • Going back by year, Other Non-Current Liabilities was $1.97 million in FY2024 (-59.4%), $4.85 million in FY2023 (-81.1%), $25.69 million in FY2022 (+14.0%) and $22.53 million in FY2021 (+239.9%).
  • The Q2 2026 figure represents the highest quarterly Other Non-Current Liabilities since Q4 2022.
  • Year-over-year, Other Non-Current Liabilities has increased for three consecutive quarters, with growth averaging 48.4% over the last eight quarters.
  • The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q3 2022 (growth of 341.0%), and the weakest in Q3 2023 (a decline of 83.1%).
  • Business Quant data shows XERS's Other Non-Current Liabilities at $8.13 million (Q1 2026), $8.4 million (Q4 2025) and $3.39 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Xeris Biopharma Holdings 1.66 Bn 1.22 Bn 79.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.72 Mn
Mar 31, 2026 8.13 Mn
Dec 31, 2025 8.40 Mn
Sep 30, 2025 3.39 Mn
Jun 30, 2025 7.75 Mn
Mar 31, 2025 4.83 Mn
Dec 31, 2024 1.97 Mn
Sep 30, 2024 8.55 Mn
Jun 30, 2024 7.71 Mn
Mar 31, 2024 6.06 Mn
Dec 31, 2023 4.85 Mn
Sep 30, 2023 5.10 Mn
Jun 30, 2023 6.91 Mn
Mar 31, 2023 9.37 Mn
Dec 31, 2022 25.69 Mn
Sep 30, 2022 30.10 Mn
Jun 30, 2022 30.22 Mn
Mar 31, 2022 25.35 Mn
Dec 31, 2021 22.53 Mn
Sep 30, 2021 6.83 Mn
API Access

Xeris Biopharma Holdings Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=XERS&period=max&api_key=YOUR_API_KEY